Exapto
Paris, FR · Founded 2024 · 4 employees on LinkedIn · 1 known investors
Exapto develops engineered biocomponents — novel patented metabolic pathways and enzymes — for industrial biomanufacturing, aimed at improving existing bioproductions and enabling access to chemicals that were previously unreachable from renewable resources. The company combines synthetic biology and AI in its R&D stack to produce key chemicals for the biomanufacturing industry.
Investors · 1
Frequently asked questions
- What does Exapto do?
- Exapto develops engineered biocomponents — novel patented metabolic pathways and enzymes — for industrial biomanufacturing, aimed at improving existing bioproductions and enabling access to chemicals that were previously unreachable from renewable resources. The company combines synthetic biology and AI in its R&D stack to produce key chemicals for the biomanufacturing industry.
- Who are Exapto's investors?
- Exapto's investors include Satgana.
- Where is Exapto headquartered?
- Exapto is headquartered in Paris, FR.